Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Monday, March 27 2017 10:47am ET - U.S. Markets close in 5 hours and 13 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Diagnostic Substances
Composite Value: 1767.8
Today's Change: +0.36%
S&P 500: -0.08%
chart for
[Diagnostic Substances (^YHOh789)]
Diagnostic Substances News
Oxford Immunotec Announces Release of New National Tuberculosis Test Data and Screening Grant for High Risk Patients on World TB Day
Thu Mar 23 (Thomson Reuters ONE)
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 23, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing ...
Atossa Genetics Opens Enrollment in Study of Endoxifen - (Marketwire)
Neogen meets 3Q profit forecasts - (AP)
More News on Diagnostic Substances: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
IDEXX Laboratories, Inc. [IDXX] +0.56% $13.5 B
Neogen Corporation [NEOG] -0.47% $2.4 B
AMAG Pharmaceuticals, Inc. [AMAG] +1.85% $755.5 M
Quidel Corporation [QDEL] +0.76% $719.6 M
Meridian Bioscience Inc. [VIVO] +1.16% $552.9 M
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
03/29/17 VRML Vermillion Inc Q4 2016 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
03/14/17 TRIB Trinity Biotech plc - American upside earnings surprise (+127.50%)
03/07/17 CEMI Chembio Diagnostics, Inc. downside earnings surprise (-40.00%)
02/28/17 OXFD Oxford Immunotec Global PLC - O upside earnings surprise (+40.54%)
More Recent Events...
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:19B
Price / Earnings:29.5
Price / Book:-13.4
Net Profit Margin (mrq):11.7%
Price To Free Cash Flow (mrq):855.9
Return on Equity:13.5%
Total Debt / Equity:68.6
Dividend Yield:3.1%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
OSCI
LEXG
DDD
Unusually Active Boards
Board Variance
ORCH
LEXG
DDD

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?